Access cutting-edge severe asthma treatment through this clinical trial at a research site in Montgomery. Study-provided care at no cost to qualified participants.
Access severe asthma specialists in Montgomery at no cost
This study follows strict safety protocols and ethical guidelines
All study-related severe asthma treatment provided free
A study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations and uncontrolled asthma receiving high-dose inhaled corticosteroid (ICS) plus at least one additional controller medication.
Sponsor: AstraZeneca
Check if you qualify for this severe asthma clinical trial in Montgomery, AL
If you're searching for severe asthma treatment options in Montgomery, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Montgomery research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.